Abstract:GATA4 (GATA-binding protein 4), a zinc finger–containing, DNA-binding transcription factor, is essential for normal cardiac development and homeostasis in mice and humans, and mutations in this gene have been reported in human heart defects. Defects in alternative splicing are associated with many heart diseases, yet relatively little is known about how cell type– or cell state–specific alternative splicing is achieved in the heart. Here, we show that GATA4 regulates cell type–specific splicing through direct interaction with RNA and the spliceosome in human induced pluripotent stem cell–derived cardiac progenitors. We leveraged a combination of unbiased approaches including affinity purification of GATA4 and mass spectrometry, enhanced cross-linking with immunoprecipitation, electrophoretic mobility shift assays, in vitro splicing assays, and unbiased transcriptomic analysis to uncover GATA4's novel function as a splicing regulator in human induced pluripotent stem cell–derived cardiac progenitors. We found that GATA4 interacts with many members of the spliceosome complex in human induced pluripotent stem cell–derived cardiac progenitors. Enhanced cross-linking with immunoprecipitation demonstrated that GATA4 also directly binds to a large number of mRNAs through defined RNA motifs in a sequence-specific manner. In vitro splicing assays indicated that GATA4 regulates alternative splicing through direct RNA binding, resulting in functionally distinct protein products. Correspondingly, knockdown of GATA4 in human induced pluripotent stem cell–derived cardiac progenitors resulted in differential alternative splicing of genes involved in cytoskeleton organization and calcium ion import, with functional consequences associated with the protein isoforms. This study shows that in addition to its well described transcriptional function, GATA4 interacts with members of the spliceosome complex and regulates cell type–specific alternative splicing via sequence-specific interactions with RNA. Several genes that have splicing regulated by GATA4 have functional consequences and many are associated with dilated cardiomyopathy, suggesting a novel role for GATA4 in achieving the necessary cardiac proteome in normal and stress-responsive conditions.

Regulation of human coagulation factor X gene expression by GATA-4 and the Sp family of transcription factors

Transcriptional regulation of the rat platelet factor 4 gene: interaction between an enhancer/silencer domain and the GATA site

Sp1, a CAAT-binding factor, and the adenovirus major late promoter transcription factor interact with functional regions of the gamma-fibrinogen promoter

Characterization of Transcriptional Regulatory Elements Within First Intron of the A Subunit Gene of Coagulation Factor ⅩⅢ

Sp family members stimulate transcription of the hex gene via interactions with GC boxes.

Coagulation factors VIIa and Xa induce cell signaling leading to up-regulation of the egr-1 gene

Transcription Factor GATA4 Regulates Cell Type–Specific Splicing Through Direct Interaction With RNA in Human Induced Pluripotent Stem Cell–Derived Cardiac Progenitors

Transcriptional Regulation of Cell-specific Expression of the Human Cystathionine β-Synthase Gene by Differential Binding of Sp1/Sp3 to the −1b Promoter

Roles of Phytanoyl-CoA α-Hydroxylase in Mediating the Expression of Human Coagulation Factor VIII

Regulation of GATA4 Transcriptional Activity in Cardiovascular Development and Disease.

Transcriptional Regulation of the Human Reduced Folate Carrier A1/A2 Promoter: Identification of Critical Roles for the Usf and Gata Families of Transcription Factors

The regulation of trefoil factor 2 expression by the transcription factor Sp3.

Kinetics and regulation of coagulation factor X activation by intrinsic tenase on phospholipid membranes

Hepatocyte Nuclear Factor 4 Alpha and Farnesoid X Receptor Co-regulates Gene Transcription in Mouse Livers on a Genome-Wide Scale

Structure And Evolution Of The Human Genes Encoding Protein-C And Coagulation Factor-Ix

Advance in the Development of Factor Xa Inhibitors

Molecular Defects in the Factor X Gene Caused by Novel Heterozygous Mutations IVS5+1G>A and Asp409del.

Characterization of the Human Thrombopoietin Gene Promoter

Severe Coagulation Factor X Deficiency Caused by Two De Novel Heterozygous Missense Mutations in Factor X Gene

Transcriptional Regulation of Heterogeneous Nuclear Ribonucleoprotein K Gene Expression.

Progress in Research of the Coagulation Factor Ix/Factor X-Binding Protein Family.